Long-acting and short-acting sulfonamides. Recent developments.
D001419:Bacteria / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004926:Escherichia coli / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D008055:Lipids; D008657:Metabolic Clearance Rate; D011485:Protein Binding; D012995:Solubility; D013411:Sulfadiazine / Q000378:metabolism; D013412:Sulfadimethoxine / Q000378:metabolism; D013416:Sulfamerazine / Q000378:metabolism; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000378:metabolism; D013432:Sulfathiazoles / Q000378:metabolism; D013444:Sulfisoxazole / Q000378:metabolism; D013449:Sulfonamides / Q000145:classification / Q000378:metabolism*; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D003692:Delayed-Action Preparations; D008055:Lipids; D013432:Sulfathiazoles; D013449:Sulfonamides; D013411:Sulfadiazine; D013412:Sulfadimethoxine; D013444:Sulfisoxazole; D013420:Sulfamethoxazole; D013421:Sulfamethoxypyridazine; D013416:Sulfamerazine